This paper describes PI-RADS v1
First paper, that describes the potential of Combidex to recognise small nodal metastases.
Updates on these papers
MRI with a lymph-node-specific contrast agent as analternative to CT scan and lymph-node dissection in patientswith prostate cancer: a prospective multicohort study.
Full PIRADS v2 paper.
Summary of PI-RADS v2 and beyond.
Web of Science